NewEdge Wealth LLC Purchases New Position in Encompass Health Corporation $EHC

NewEdge Wealth LLC bought a new position in shares of Encompass Health Corporation (NYSE:EHC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,113 shares of the company’s stock, valued at approximately $517,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. WPG Advisers LLC increased its holdings in Encompass Health by 73.3% during the 4th quarter. WPG Advisers LLC now owns 324 shares of the company’s stock worth $34,000 after purchasing an additional 137 shares during the last quarter. Persistent Asset Partners Ltd purchased a new position in shares of Encompass Health during the 2nd quarter valued at approximately $36,000. Assetmark Inc. grew its position in shares of Encompass Health by 89.6% during the first quarter. Assetmark Inc. now owns 455 shares of the company’s stock worth $44,000 after buying an additional 215 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its position in shares of Encompass Health by 36,200.0% during the third quarter. Caitong International Asset Management Co. Ltd now owns 363 shares of the company’s stock worth $46,000 after buying an additional 362 shares in the last quarter. Finally, Aster Capital Management DIFC Ltd bought a new stake in shares of Encompass Health in the fourth quarter worth $55,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on EHC shares. Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a report on Sunday, August 16th. Barclays boosted their target price on shares of Encompass Health from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Truist Financial upped their target price on shares of Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, August 7th. UBS Group lifted their price target on Encompass Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, August 7th. Finally, Weiss Ratings upgraded Encompass Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company’s stock. According to MarketBeat.com, Encompass Health presently has a consensus rating of “Buy” and a consensus price target of $148.71.

Encompass Health Stock Down 0.6%

Encompass Health stock opened at $120.24 on Friday. The company has a 50-day simple moving average of $111.01 and a 200-day simple moving average of $106.38. The firm has a market capitalization of $11.86 billion, a P/E ratio of 19.58, a P/E/G ratio of 2.44 and a beta of 0.72. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.19 and a current ratio of 1.19. Encompass Health Corporation has a one year low of $92.77 and a one year high of $127.99.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.48 by $0.07. The firm had revenue of $1.60 billion for the quarter, compared to the consensus estimate of $1.57 billion. Encompass Health had a net margin of 10.01% and a return on equity of 18.08%. Encompass Health’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period last year, the firm posted $1.40 EPS. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. As a group, equities analysts expect that Encompass Health Corporation will post 6.09 earnings per share for the current year.

Encompass Health Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. This is a boost from Encompass Health’s previous quarterly dividend of $0.19. The ex-dividend date of this dividend is Thursday, October 1st. Encompass Health’s dividend payout ratio is presently 12.38%.

Insider Activity at Encompass Health

In other news, EVP John Patrick Darby sold 8,906 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.95, for a total transaction of $1,121,710.70. Following the completion of the transaction, the executive vice president directly owned 75,041 shares in the company, valued at approximately $9,451,413.95. The trade was a 10.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Mark J. Tarr sold 173,148 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the transaction, the chief executive officer directly owned 267,814 shares of the company’s stock, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders own 1.80% of the company’s stock.

About Encompass Health

Encompass Health Corporation is a leading provider of post?acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end?of?life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.